Celera Genomics
This article was originally published in The Gray Sheet
Executive Summary
Provider of genomic and related medical information agrees to acquire privately held Paracel, producer of advanced genomic and text analysis technologies, for stock valued at $283 mil. Pasadena, California-based Paracel's products include GeneMatcher, "the world's fastest sequence comparison supercomputer," high-throughput sequence analysis and annotation software tools, and the TextFinder text search supercomputer. "We believe Paracel's advanced supercomputing technology and expertise is synergistic with Celera's comprehensive genomics content enabling us to create the premier genomic discovery portal," Celera says